Ensysce Biosciences (ENSCW) Return on Sales (2020 - 2025)

Ensysce Biosciences (ENSCW) has 6 years of Return on Sales data on file, last reported at 0.08% in Q3 2025.

• Return on Sales for Q3 2025 came in at 0.08%, down 8.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.02% (down 1.0% YoY), and the FY2024 annual result was 0.02%, up 3.0% from the prior year.
• Return on Sales slipped to 0.08% in Q3 2025 per ENSCW's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q3 2024 and troughed at 0.34% in Q2 2022.
• A 5-year average of 0.08% and a median of 0.06% in 2023 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2023: Return on Sales plunged 31 bps in 2022, then gained 30 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then plunged by 250 bps to 0.04% in 2022, then sank by 57 bps to 0.07% in 2023, then soared by 60 bps to 0.03% in 2024, then tumbled by 177 bps to 0.08% in 2025.
• Business Quant data shows ENSCW's Return on Sales at 0.08% in Q3 2025, 0.01% in Q2 2025, and 0.01% in Q1 2025.